The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Bayer Aktiengesellschaft ( BAYRY) Q4 2025 Earnings Call March 4, 2026 8:00 AM EST ...

Evan Soltas and Jonathan Gruber have published a paper titled, “How Costly Is Permitting in Housing Development?”. They ...

Indivior Pharmaceuticals, Inc. ( INDV) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Good morning, everyone. I am joined today by Joe Ciaffoni, Chief Executive Officer; Pat Barry, Chief ...

The dining room table is the civic and moral hearth of our house on Constitution Street. Upon it rest a stack of utility and other bills to be sorted and paid (with cursing as necessary), issues of ...

Volt Carbon Technologies Inc. (TSXV: VCT) (OTCQB: TORVF) (“Volt Carbon” or the “Company”) announces that it will be exhibiting at PDAC 2026 ...

Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane’ or ‘the Company’) is pleased to announce the latest exploration results for the extension and infill drilling of the Kendal ...

Deere & Company (NYSE:DE) Q1 2026 Earnings Call Transcript February 19, 2026 Deere & Company beats earnings expectations. Reported EPS is $2.42, expectations were $2.02. Operator: Good morning, and ...

Why has the FIA given the power unit manufacturers a reprieve until August to make changes, should an e-vote for a rule change pass?

OGE Energy Corp. (NYSE:OGE) Q4 2025 Earnings Call Transcript February 18, 2026 OGE Energy Corp. beats earnings expectations. Reported EPS is $0.34, expectations were $0.3. Operator: Good day, and ...

Expro Group Holdings N.V. (NYSE:XPRO) Q4 2025 Earnings Call Transcript February 19, 2026 Expro Group Holdings N.V. beats earnings expectations. Reported EPS is $0.506, expectations were $0.21.